|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 49/00 | |
| A61K 39/395 | |||
| C07K 16/00 | |||
| G01N 33/53 |
| (11) | Number of the document | 3096798 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15740774.3 |
| Date of filing the European patent application | 2015-01-21 | |
| (97) | Date of publication of the European application | 2016-11-30 |
| (45) | Date of publication and mention of the grant of the patent | 2020-11-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/012212 |
| Date | 2015-01-21 |
| (87) | Number | WO 2015/112578 |
| Date | 2015-07-30 |
| (30) | Number | Date | Country code |
| 201461929716 P | 2014-01-21 | US | |
| 201461944361 P | 2014-02-25 | US | |
| 201462021397 P | 2014-07-07 | US |
| (72) |
CHYUNG, Yung, US
SEXTON, Daniel J., US
TENHOOR, Christopher, US
KENNISTON, Jon A., US
FAUCETTE, Ryan, US
IARROBINO, Ryan, US
BIEDENKAPP, Joseph, US
ADELMAN, Burt, US
|
| (73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome
Chuo-ku, Osaka-shi, Osaka,
JP
|
| (54) | PLASMA KALLIKREIN BINDING PROTEINS AND USES THEREOF IN TREATING HEREDITARY ANGIOEDEMA |
| PLASMA KALLIKREIN BINDING PROTEINS AND USES THEREOF IN TREATING HEREDITARY ANGIOEDEMA |